treatment of gastric cancer after first metastasis
Showing 1 - 25 of >10,000
Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (XELOX combined with Fruquintinib and Sintilimab)
Not yet recruiting
- Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
- XELOX combined with Fruquintinib and Sintilimab
- (no location specified)
Oct 17, 2023
Gastric Cancer Metastatic to Liver Trial in Shanghai (Cryoablation, Tislelizumab, Lenvatinib)
Not yet recruiting
- Gastric Cancer Metastatic to Liver
- Cryoablation
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 6, 2023
Gastric Cancer Trial (HIPEC,anti-PD-1 antibody Sintilimab (Tyvyt®), Chemotherapy,Surgery)
Not yet recruiting
- Gastric Cancer
- HIPEC,anti-PD-1 antibody Sintilimab (Tyvyt®), Chemotherapy,Surgery
- (no location specified)
Dec 14, 2022
Peritoneal Metastasis for Gastric Cancer Based on Radiomics
Recruiting
- Gastric Cancer
- Peritoneal Metastases
- Peritoneal metastasis status ascertainment
-
Beijing, China
- +12 more
Feb 12, 2023
Gastric Cancer, Peritoneal Metastases, Ascites, Malignant Trial in Hangzhou (Sintilimab in Combination With S-1/oxaliplatin With
Recruiting
- Gastric Cancer
- +2 more
- Sintilimab in Combination With S-1/oxaliplatin With nab-paclitaxel intraperitoneal infusion
- Blood samples, tumor biopsy specimens, ascites, and feces samples will be collected
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 18, 2023
HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With
Not yet recruiting
- Gastric Cancer
- Observational
- (no location specified)
Dec 13, 2022
Gastric Carcinoma Trial in China (Yiqi Wenyang Jiedu prescription, Simulation agent of Yiqi Wenyang Jiedu prescription)
Recruiting
- Gastric Carcinoma
- Yiqi Wenyang Jiedu prescription
- Simulation agent of Yiqi Wenyang Jiedu prescription
-
Beijing, Beijing, China
- +5 more
Oct 31, 2022
Gastric Cancer, Lymph Node Metastasis Trial in Lublin (Sentinel Node Assessment, Staging laparoscopy, Gastroscopy with
Recruiting
- Gastric Cancer
- Lymph Node Metastasis
- Sentinel Node Assessment
- +2 more
-
Lublin, PolandMedical University of Lublin
Jan 31, 2023
Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) Trial in Tianjin (Serplulimab+Paclitaxel+Apatinib,
Recruiting
- Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Jul 5, 2023
HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811, Ramucirumab / Paclitaxel/
Not yet recruiting
- HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
- SHR-A1811
- Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
- (no location specified)
Nov 6, 2023
Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin
Recruiting
- Gastric Cancer
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Oct 22, 2023
Gastric Cancer Trial in Qingdao (Hyperthermic Intraperitoneal Chemotherapy (HIPEC))
Recruiting
- Gastric Cancer
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
May 14, 2023
ValidateRisk Scoring Model for HMGC After Curative Surgery
Not yet recruiting
- Predictive Cancer Model
- +2 more
-
Tianjin, 天津, ChinaCancer Hospital of Tianjin Medical University
Sep 5, 2023
Gastric Cancer Liver Metastasis Cohort of China
Active, not recruiting
- Stomach Neoplasms
- Neoplasm Metastasis
- Gastrectomy; Hepatectomy
-
Beijing, Beijing, ChinaGeneral Surgery Institute, China PLA General Hospital
Oct 3, 2022
Liver Metastasis Colon Cancer Trial in Guangzhou (TACE and HAIC Combined With Regorafenib)
Not yet recruiting
- Liver Metastasis Colon Cancer
- TACE and HAIC Combined With Regorafenib
-
Guangzhou, Guangdong, Chinathe first affiliated hospital, Sun-Yat sen university
Oct 2, 2023
Gastric Cancer, Gastroesophageal-junction Cancer Trial (Tcrx T cell)
Not yet recruiting
- Gastric Cancer
- Gastroesophageal-junction Cancer
- Tcrx T cell
- (no location specified)
Jul 21, 2022
Carcinoma Trial in Taoyuan City
Recruiting
- Carcinoma
-
Taoyuan City, TaiwanChang Gung Memorial Hospital
Feb 21, 2023
Multiple Coagulation-related Factors and Lymph Node Metastasis
Recruiting
- Gastric Cancer Stage
- Lymph Node Metastasis
- coagulation-related factors
-
Jinan, Shandong, ChinaShandong Provincial Hospital
Oct 21, 2022
CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer
Recruiting
- Stomach Neoplasms
- Metastasis
- CTC test
- ctDNA test
-
Jinzhou, Liaoning, China
- +1 more
Jan 13, 2022
Stage IV Gastric Cancer With Metastasis Trial (Camrelizumab; Nab-paclitaxel; S-1)
Not yet recruiting
- Stage IV Gastric Cancer With Metastasis
- Camrelizumab; Nab-paclitaxel; S-1
- (no location specified)
Jul 5, 2022
Tislelizumab Combined With Chemotherapy in First-line Treatment
Active, not recruiting
- Tislelizumab
- +3 more
-
Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 6, 2023
Genomic Evolution of Metastasis in Gastric Cancer
Recruiting
- Gastric Cancer
- Metastasis
-
Ho Chi Minh City, VietnamUniversity Medical Center Ho Chi Minh City
Apr 27, 2022
Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Rochester
Not yet recruiting
- Clinical Stage IV Gastric Cancer AJCC v8
- +4 more
- Aldesleukin
- +10 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 5, 2023